Critical evaluation of the scientific content in clinical practice guidelines

Cancer

Volumn 121, Issue 5, 2015, Pages 783-789

  Abdelsattar, Zaid M ^a   Reames, Bradley N ^a   Regenbogen, Scott E ^a   Hendren, Samantha ^a   Wong, Sandra L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Evidence based medicine; Health services; Organizations; Practice guidelines; Rectal neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; DRUG EFFECT; EVALUATION RESEARCH; EVIDENCE BASED PRACTICE; HIGH RISK PATIENT; HUMAN; LOW RISK PATIENT; PRACTICE GUIDELINE; PREOPERATIVE CARE; PRIORITY JOURNAL; RECTUM CANCER; TREATMENT PLANNING; DISEASE MANAGEMENT; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; RECTAL NEOPLASMS; STANDARDS;

DISEASE MANAGEMENT; EVIDENCE-BASED MEDICINE; GUIDELINE ADHERENCE; HUMANS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; RECTAL NEOPLASMS;

EID: 84923291139     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29124     Document Type: Article

References (26)

1. Grilli R, Magrini N, Penna A, Mura G, Liberati A. Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet. 2000; 355:103-106.
2. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999; 282:1458-1465.
3. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003; 348: 2635-2645.
4. Greenberg CC, Lipsitz SR, Neville B, et al. Receipt of appropriate surgical care for Medicare beneficiaries with cancer. Arch Surg. 2011; 146:1128-1134.
5. Sox HC. Assessing the trustworthiness of the guideline for management of high blood pressure in adults. JAMA. 2014; 311:472-474.
6. Reames BN, Krell RW, Ponto SN, Wong SL. Critical evaluation of oncology clinical practice guidelines. J Clin Oncol. 2013; 31:2563-2568.
7. Kung J, Miller RR, Mackowiak PA. Failure of clinical practice guidelines to meet institute of medicine standards: two more decades of little, if any, progress. Arch Intern Med. 2012; 172:1628-1633.
8. Graham R, Mancher M, Wolman D. Clinical Practice Guidelines We Can Trust. Washington, DC: National Academies Press; 2011:1-300.
9. Levit L, Balogh E, Nass S, Ganz PA. Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis. Washington, DC: National Academies Press; 2013.
10. Monson JRT, Weiser MR, Buie WD, et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum. 2013; 56:535-550.
11. Smith AJ, Driman DK, Spithoff K, et al. Optimization of Surgical and Pathological Quality Performance in Radical Surgery for Colon and Rectal Cancer: Margins and Lymph Nodes Optimization of Surgical and Pathological Quality Performance in Radical Surgery for Colon and Rectal Cancer: Margins a. Toronto: Program in Evidence-Based Care; 2013:7-14.
12. Earle C, Annis R, Sussman J, Haynes AE, Vafaei A. A Quality Initiative of the Program in Evidence-based Care (PEBC), Cancer Care Ontario Follow-up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer A Quality Initiative of the Program in Evidence-based Ca. Program in Evidence-Based Care; 2012.
13. Chan K, Welch S, Raifu AO. PET Imaging in Colorectal Cancer. Program in Evidence-Based Care; 2011.
14. Wong R, Berry S, Spithoff K, et al. Preoperative or Postoperative Therapy for the Management of Patients with Stage II or III Rectal Cancer Preoperative or Postoperative Therapy for the Management of Patients with Stage II or III Rectal Cancer: Guideline Recommendations. Program in Evidence-Based Care; 2011:2-4.
15. Glimelius B, Tiret E, Cervantes A, Arnold D. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013; 24(Suppl 6):vi81-vi88.
16. NCCN. Practice Guidelines in Oncology-Rectal Cancer. 2014.
17. National Institute for Health and Care Excellence. Colorectal Cancer: The Diagnosis and Management of Colorectal Cancer. London: National Institute for Health and Care Excellence; 2011.
18. Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010; 182:E839-E842.
19. WHO Handbook for Guideline Development. Geneva, Switzerland: World Health Organization; 2012.
20. Van de Ven AH, Delbecq AL. The nominal group as a research instrument for exploratory health studies. Am J Public Health. 1972; 62:337-342.
21. Raine R, Sanderson C, Hutchings A, Carter S, Larkin K, Black N. An experimental study of determinants of group judgments in clinical guideline development. Lancet. 364:429-437.
22. Arriaga AF, Lancaster RT, Berry WR, et al. The better colectomy project: association of evidence-based best-practice adherence rates to outcomes in colorectal surgery. Ann Surg. 2009; 250:507-513.
23. Bosset J-F, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006; 355:1114-1123.
24. Collette L, Bosset J-F, den Dulk M, et al. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Rad. J Clin Oncol. 2007; 25:4379-4386.
25. Minsky BD. Adjuvant management of rectal cancer: the more we learn, the less we know. J Clin Oncol. 2007; 25:4339-4340.
26. Monson JRT, Probst CP, Wexner SD, et al. Failure of evidence-based cancer care in the United States: the association between rectal cancer treatment, cancer center volume, and geography. Ann Surg. 2014; 260:625-632.